A Chinese multicentre trial reveals that using glycated albumin to guide early treatment of newly diagnosed type 2 diabetes does not improve HbA1c target achievement but enhances metabolic control and could influence treatment strategies. A multicentre randomised trial in China…
Recent research uncovers the role of the gene TEAD1 in the tissue changes driving diabetic erectile dysfunction, revealing new possibilities for targeted therapies beyond blood sugar control. New research suggests that a gene called TEAD1 may help drive the tissue…
A comprehensive meta-analysis suggests that long-term use of artificial sweeteners may significantly elevate the risk of type 2 diabetes, prompting calls for more cautious consumption and healthier alternatives. Artificial sweeteners, long marketed as a way to cut sugar without sacrificing…
Excess intake of starch-derived sweeteners, especially from soft drinks, accelerates absorption, strains the liver, and heightens risks of obesity, insulin resistance, and type 2 diabetes, with implications for pregnancy and childhood health, says Prof. Dr. Okan Bülent Yıldız. Excess consumption…
A nine-year-old boy from East Sussex has participated in a groundbreaking UK study aimed at detecting early signs of type 1 diabetes in children, as researchers explore new approaches for early diagnosis and prevention. A nine-year-old boy from East Sussex…
Emerging guidance suggests that focusing on the quality and portion of carbohydrate-rich foods, rather than carbohydrate quantity alone, can aid blood sugar control, weight management, and heart health. A low glycaemic index diet is less about cutting carbohydrates than choosing…
The worldwide market for diabetes treatments is projected to reach $163.79 billion by 2034, driven by demographic shifts and innovative drug classes that are transforming care beyond glucose management. The global market for diabetes medicines is expected to reach $163.79…
Scientists have developed a genetically engineered probiotic that detects rising glucose levels and automatically administers treatment within the gut, offering a potential revolution in personalised diabetes management. Scientists have engineered a probiotic that behaves like a biological sensor, switching on…
Amid South-West Florida’s storm season, experts emphasise the importance of proactive foot care for people with diabetes. From preparing a dedicated kit to daily inspections, steps taken weeks in advance can prevent serious injuries and complications when floodwaters and power…
Amylyx Pharmaceuticals is set to announce the topline results of its pivotal Phase 3 LUCIDITY trial testing avexitide, a potential treatment for post-bariatric hypoglycaemia, on 18 August, as the company prepares for a possible market launch in 2027. Amylyx Pharmaceuticals…
